Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-06

Clinical Trial Update: Efficacy of Remifentanil in Preventing Emergence Agitation [NA]

View source ↗

Summary

A clinical trial is evaluating whether remifentanil can prevent emergence agitation after anesthesia. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil (remifentanil)

Snippet

Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital | Conditions: Emergence Agitation | NA | Status: RECRUITING